Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-396208
Filing Date
2014-11-04
Accepted
2014-11-04 16:06:14
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d782407d10q.htm 10-Q 635753
2 EX-31.1 d782407dex311.htm EX-31.1 8873
3 EX-31.2 d782407dex312.htm EX-31.2 8837
4 EX-32.1 d782407dex321.htm EX-32.1 4278
5 EX-32.2 d782407dex322.htm EX-32.2 4236
  Complete submission text file 0001193125-14-396208.txt   3585027

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rcpt-20140930.xml EX-101.INS 392919
7 XBRL TAXONOMY EXTENSION SCHEMA rcpt-20140930.xsd EX-101.SCH 40573
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcpt-20140930_cal.xml EX-101.CAL 52609
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcpt-20140930_def.xml EX-101.DEF 98785
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcpt-20140930_lab.xml EX-101.LAB 307606
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcpt-20140930_pre.xml EX-101.PRE 207828
Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121 858-652-5700
Receptos, Inc. (Filer) CIK: 0001463729 (see all company filings)

EIN.: 264190792 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35900 | Film No.: 141193211
SIC: 2834 Pharmaceutical Preparations